<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: In animal models and in vitro studies leptomeninges have been shown to be the origin of neurotrophic substances that support the survival and growth of neuronal cells </plain></SENT>
<SENT sid="1" pm="."><plain>Because <z:hpo ids='HP_0000726'>dementia</z:hpo> is associated with <z:hpo ids='HP_0002529'>neuronal loss</z:hpo>, we investigated whether leptomeningeal dysfunction may be involved in the pathogenesis of <z:hpo ids='HP_0000726'>dementia</z:hpo> disorders </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We analysed the cerebrospinal fluid (CSF) concentrations of the leptomeningeal derived beta trace protein, beta2 microglobulin, and cystatin C </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There was a statistically significant difference of the CSF beta trace protein levels among different groups </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with idiopathic <z:hpo ids='HP_0002343'>normal pressure hydrocephalus</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e>) (17.5 (SD 4.3) mg/l) showed significantly lower CSF beta trace protein levels than patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (23.8 (6.2) mg/l), <z:hpo ids='HP_0000716'>depression</z:hpo> (24.2 (7.3) mg/l), and <z:mpath ids='MPATH_458'>normal</z:mpath> controls (25.3 (4.9) mg/l) </plain></SENT>
<SENT sid="5" pm="."><plain>To patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (20.1 (5.6) mg/l) and <z:hpo ids='HP_0002145'>frontotemporal dementia</z:hpo> (21.9 (7.0) mg/l), the difference was not significant </plain></SENT>
<SENT sid="6" pm="."><plain>There was no significant difference regarding the CSF and serum concentrations of beta2 microglobulin or cystatin C among the different groups </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: We conclude that leptomeningeal dysfunction may be involved in certain types of <z:hpo ids='HP_0000726'>dementia</z:hpo> such as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> and that reduced CSF beta trace protein levels in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> may aid in differentiating this difficult to diagnose disorder from other syndromes such as <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
</text></document>